Olivier Heyraud
Member of the Board of Directors at Pharmaleads
Last Updated:
December 07, 2019
United Kingdom
Contact Information
Access Olivier's direct phone and email
Company Information

Pharmaleads is an emerging pharmaceutical company developing innovative products for the management of acute and chronic severe pain, a growing market with significant unmet medical need. Pharmaleads' drugs are based on its deep knowledge and understanding of enkephalins, a key element of the body's natural pain management system.\Pharmaleads' products, (Dual ENKephalinase inhibitors) DENKIs, aim to protect enkephalins, hence increasing their local concentrations and thereby inducing a physiological analgesia which improves pain management. \Pharmaleads has two products in clinical development which are targeting four multi-billion markets: ----- Pharmaleads aims to provide patients suffering from severe chronic and acute pain with improved pain relief without the side effects associated with other classes of analgesics. Based on years of experience in the design of highly potent and specific inhibitors of enkephalinases, Pharmaleads has developed a new class of analgesics called DENKIs (Dual Enkephalinases inhibitors). These small molecules are able to provide patients with local and sustainable pain relief. Pharmaleads’ DENKIs are first-in-class drugs with a novel mechanism of action tackling pain by using endogenous enkephalins, natural peptides that specifically bind to pain-related opioid receptors to naturally modulate pain without the side effects observed with exogenous opioid drugs that also bind to other opioids receptors, not involved in pain control, triggering multiple side effects. Pharmaleads believes its products can change the lives of the many patients who are in need of improved treatment options for their chronic and/or acute pain, and could offer healthcare providers with an improved pain management option that helps address the opioid epidemic.......Read More
Location
France
Contact Number
+33 1 44 06 70 00
No. of Employees
9
Revenue
$17.5M
Social Links
Alexa logo
Keywords
dual enkephalinase inhibitors, pain, metalloprotease, chemistry, biotechnology
Others Named Olivier Heyraud

Chargé projet at Clextral
Responsable Commercial Grands Comptes
Browse Apollo's Directories

Company Search

Company Directory Search

People Search

People Directory Search

Find Verified Emails in Seconds

Use Apollo to easily get in touch with anyone in the world